12 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
1 | 31296923 | Association of post-operative CEA with survival and oxaliplatin benefit in patients with stage II colon cancer: a post hoc analysis of the MOSAIC trial. | 2019 Aug | 2 |
2 | 29491106 | Case Report: CEA Elevation Can Be a Marker of Increased Inflammation During Treatment with Oxaliplatin. | 2018 Mar | 4 |
3 | 28685553 | Application of oxaliplatin in combination with epirubicin in transcatheter arterial chemoembolization in the treatment of primary liver carcinoma. | 2017 Apr-Jun | 1 |
4 | 25862901 | Post-chemotherapeutic CEA and CA19-9 are prognostic factors in patients with colorectal liver metastases treated with hepatic resection after oxaliplatin-based chemotherapy. | 2015 Apr | 1 |
5 | 25731304 | [Rectal cancer with local re-recurrence successfully treated by carbon ion radiotherapy]. | 2014 Nov | 1 |
6 | 23863744 | [Successful treatment of a patient using mFOLFOX6 after laparoscopic surgery for rectal cancer with peritoneal dissemination]. | 2013 Jul | 1 |
7 | 22236191 | CEA and CA19.9 as early predictors of progression in advanced/metastatic colorectal cancer patients receiving oxaliplatin-based chemotherapy and bevacizumab. | 2012 Jan | 1 |
8 | 22524576 | A retrospective cohort study of metastatic colorectal cancer patients treated with oxaliplatin-based chemotherapy, with an exploratory analysis of changing serum carcinoembryonic antigen levels. | 2012 Jun | 3 |
9 | 20110784 | Colorectal cancer: response to sunitinib in a heavily pretreated colorectal cancer patient. | 2010 Jan | 1 |
10 | 20121626 | Carcinoembryonic antigen surge in metastatic colorectal cancer patients responding to irinotecan combination chemotherapy. | 2010 May | 4 |
11 | 18577244 | Combined effects of 5-fluorouracil, folinic acid and oxaliplatin on the expression of carcinoembryonic antigen in human colon cancer cells: pharmacological basis to develop an active antitumor immunochemotherapy. | 2008 May 19 | 3 |
12 | 15360055 | Transient CEA increase at start of oxaliplatin combination therapy for metastatic colorectal cancer. | 2004 | 2 |